To assess the extra- and intracellular uptake of the anticancer drug fluorouracil and its major catabolite alpha-fluoro-beta-alanine (FBAL) at gadolinium-enhanced fluorine-19 magnetic resonance (MR) imaging.
Forschungsschwerpunkt Radiologische Diagnostik und Therapie (Research Program Radiologic Diagnostics and Therapy), Deutsches Krebsforschungszentrum, Heidelberg, Germany.
